Atlanta, GA- Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, announced today that it has selected ten semifinalists in its second annual BIO/Plan Competition. (more…)

Program Promotes New, Venture-Attractive Life Sciences Companies in the Southeast

Atlanta, GA – – Southeast BIO (SEBIO), a regional
nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, announced today its second annual BIO/Plan Competition. The year-long program has been designed and developed to help promote the creation of new, venture-attractive life science companies based in the Southeast. Working closely with tech transfer offices and entrepreneurs throughout the region, the competition pulls opportunities forward from our region’s research universities, research centers and experienced entrepreneurs.
(more…)

Atlanta, GA – Southeast BIO (SEBIO) today announced its 2008 SEBIO Investor Forum, set for December 4-5, 2008, at the Breakers Resort in Palm Beach, FL. The chair of this year’s event is David Day, Director, Office of Technology Licensing, University of Florida. (more…)

Atlanta, GA — Southeast BIO (SEBIO) has elected its new 2008 Board of Directors to lead the organization through its next year of operations. (more…)

Atlanta, GA— Southeast BIO (SEBIO) announced four winners of the First Annual SEBIO Awards in a ceremony held at its Ninth Annual Investor Forum in Pinehurst, NC on November 8th. The awards honored companies in the following categories: Southeast (SE) Deal of the Year: Initial Funding; SE Deal of the Year: Venture Capital Transaction and SE Deal of the Year: Strategic Transaction. In addition, the organization awarded its inaugural SE Leadership Award to an individual or organization that made a notable contribution to the growth of the life sciences industry in the region over the last year. The winners were Argolyn Bioscience, Inc., Metastatix, Inc, Targacept, Inc., and Aaron Davidson of HIG Ventures, respectively. (more…)

Atlanta, GA- Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, has announced the winner of its first annual BIO/Plan Competition, a year long business creation competition. The winner is Triptcor Pharmaceuticals, a pre-incorporated technology to be spun-out of Emory University. Triptcor will take home the $100,000.00 (non-dilutive) BIO/Plan 1st prize. (more…)

Atlanta, GA– More than 400 people attended the Ninth Annual Southeastern BIO Investor Forum on November 7th-8th in Pinehurst, North Carolina. The Forum is the Southeast’s premier life sciences venture capital conference. (more…)

Atlanta, GA – Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, announced today the selection of four finalists in its first annual BIO/Plan Competition. The final four competitors are: CureFAKtor, Inc. (University of Florida); Triptor Pharmaceuticals (Emory University); SpherIngenics, Inc. (Georgia Institute of Technology); and Oncoscope, Inc. (Duke University). (more…)

Atlanta, GA – Southeast BIO (SEBIO) today announced the keynote speakers and featured panelists for the Ninth Annual Southeastern BIO Investor Forum. The Forum, scheduled for November 7-8, 2007 at the Pinehurst Resort in Pinehurst, NC, will feature remarks from more than 14 industry leaders. (more…)

Atlanta, GA– Southeast BIO (SEBIO) announced today it has selected 24 companies to participate in its Southeastern BIO Investor Forum, an event that brings together the Southeast’s most promising life sciences venture opportunities with the regional and national venture capital community. (more…)